DALLAS-FORT WORTH, TX— November 21, 2025 — BioStone Animal Health is pleased to announce the launch of the AsurDxTM Trypanosoma Cruzi Real-Time PCR Detection Kit designed for the detection of Trypanosoma Cruzi (causative agent of Chagas Disease) in dog whole blood and feces.
About Trypanosoma cruzi and Chagas Disease
Chagas disease, caused by the parasite Trypanosoma cruzi, is a serious and potentially life-threatening illness that affects both animals and humans. The parasite is primarily transmitted through contact with infected triatomine insects (“kissing bugs”), but infection can also occur through contaminated food, congenital transmission, or blood transfusion. In dogs, Chagas disease can lead to a wide range of clinical signs—including lethargy, fever, enlarged lymph nodes, cardiac abnormalities, and, in severe cases, sudden death.
Early and accurate detection is critical for managing disease spread and monitoring the health of at-risk animals. The AsurDx™ Trypanosoma cruzi Real-Time PCR Detection Kit provides sensitive and specific detection of T. cruzi DNA in whole blood and fecal samples, supporting surveillance efforts, diagnostic workflows, and research applications. With a streamlined workflow and robust performance, the kit helps deliver reliable and reproducible results for effective disease control.
About BioStone Animal Health — BioStone Animal Health is a Dallas, TX-based biotechnology company that provides innovative solutions for animal health. BioStone Animal Health works together with our worldwide partners to offer a portfolio of animal disease diagnostic products as well as test kits and reagents for vaccine testing that enables performing a rapid evaluation of the efficacies, stability, consistency, and potency of common animal vaccines. By making these test kits available to the international community, BioStone strives to actively promote and participate in global animal health initiatives. For more information about BioStone Animal Health, visit www.biostoneah.com
